Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
6,527,911
-
Share change
-
+3,143,285
-
Total reported value
-
$6,492,793
-
Price per share
-
$0.99
-
Number of holders
-
27
-
Value change
-
+$2,554,008
-
Number of buys
-
13
-
Number of sells
-
17
Institutional Holders of VTV THERAPEUTICS INC - CL A (VTVT) as of Q4 2021
As of 31 Dec 2021,
VTV THERAPEUTICS INC - CL A (VTVT) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,527,911 shares.
The largest 10 holders included
VANGUARD GROUP INC, Samsara BioCapital, LLC, EcoR1 Capital, LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, CIM INVESTMENT MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., and Virtu Financial LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.